Twelve months of emicizumab prophylaxis in a severe hemophilia A man with inhibitor who failed immune tolerance induction: effectiveness, economic, and safety outcomes

被引：0
|
作者：
Camelo, Ricardo Mesquita [1 ]
de Medeiros, Tenille Capuxu [2 ]
de Albuquerque, Daniela Goncalves Braz [2 ]
Alvares-Teodoro, Juliana [3 ]
机构：
[1] Univ Fed Minas Gerais, Fac Med, 1020-101 Padre Eustaquio, Belo Horizonte, MG, Brazil
[2] Ctr Hematol & Hemoterapia Rio Grande Norte HEMONOR, Natal, RN, Brazil
[3] Univ Fed Minas Gerais, Fac Farm, Belo Horizonte, MG, Brazil
来源：
HEMATOLOGY TRANSFUSION AND CELL THERAPY | 2023年 / 45卷 / 01期
关键词：
D O I：
10.1016/j.htct.2021.02.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：98 / 101
页数：4
相关论文
共 41 条
  • [21] Low-dose immune tolerance induction therapy in severe hemophilia a children in China: Starting earlier resulted in better inhibitor eradication outcomes
    Li, Zhengping
    Sun, Jie
    Li, Zekun
    Chen, Zhenping
    Liu, Guoqing
    Yao, Wanru
    Li, Gang
    Zhen, Yingzi
    Cheng, Xiaoling
    Ai, Di
    Huang, Kun
    Poon, Man-Chiu
    Wu, Runhui
    THROMBOSIS RESEARCH, 2023, 225 : 33 - 38
  • [22] LOW-DOSE IMMUNE TOLERANCE INDUCTION THERAPY IN SEVERE HEMOPHILIA A CHILDREN WITH HIGH-TITER INHIBITOR
    Elalfy, M. S.
    Elghamry, I.
    Hassab, H.
    Elalfy, O.
    Andrawes, N. G.
    El-Ekiaby, M.
    HAEMOPHILIA, 2021, 27 : 97 - 97
  • [23] Long-term outcomes of patients with severe hemophilia A and high titer inhibitors with partial tolerance after immune tolerance induction
    Batsuli, Glaivy
    Meeks, Shannon
    Sidonio, Robert
    HAEMOPHILIA, 2018, 24 : 48 - 49
  • [24] Economic Comparison Of Treating Hemophilia Patients Who Have Developed Inhibitors Via Immune Tolerance Induction Versus Prophylaxis and On-Demand Treatment With Bypassing Agents
    Earnshaw, Stephanie R.
    McDade, Cheryl L.
    Graham, Christopher N.
    Spears, Jeffrey B.
    Kessler, Craig M.
    BLOOD, 2013, 122 (21)
  • [25] Use of rVIII-Singlechain in Tolerance Induction: Intensified Prophylaxis Regimen in a Pediatric Patient with Severe Hemophilia A and a low Titer Inhibitor
    Ong, J.
    Feussner, A.
    Kalina, U.
    Veldman, A.
    St Ledger, K.
    HAEMOPHILIA, 2017, 23 : 33 - 34
  • [26] Prophylactic treatment and Rituximab subsequent immune tolerance induction therapy to improve inhibitor eradication on resistant ITI in severe hemophilia A patients with inhibitor
    Chen, Yeu-Chin
    Cheng, Shin-Nan
    HAEMOPHILIA, 2016, 22 : 69 - 69
  • [27] Use of Haemate® P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study
    Rothschild, C.
    D'oiron, R.
    Borel-derlon, A.
    Gruel, Y.
    Navarro, R.
    Negrier, C.
    HAEMOPHILIA, 2013, 19 (02) : 281 - 286
  • [28] SUCCESSFUL SUPPRESSION OF FACTOR VIII INHIBITOR TITERS WITH IMMUNE TOLERANCE INDUCTION IN AN INFANT WITH SEVERE HEMOPHILIA A DUE TO EXON DUPLICATION
    Ghanim, Majd
    Robinson, Mayra
    Bergmann, Shayla
    PEDIATRIC BLOOD & CANCER, 2018, 65
  • [29] rFIXFc for Immune Tolerance Induction in a Severe Hemophilia B Patient with an Inhibitor and Prior History of ITI Related Nephrotic Syndrome
    Malec, Lynn
    Abshire, Thomas
    Jobe, Shawn
    White, Gilbert
    HAEMOPHILIA, 2018, 24 (04) : E294 - E296
  • [30] Successful immune tolerance induction in a severe 66-year old hemophilia a patient with a high-titre inhibitor
    Lassila, R.
    Asmundela, H.
    Armstrong, E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 934 - 934
12345